First Time Loading...

Exscientia PLC
NASDAQ:EXAI

Watchlist Manager
Exscientia PLC Logo
Exscientia PLC
NASDAQ:EXAI
Watchlist
Price: 4.02 USD -0.25%
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

EXAI Price Targets Summary
Exscientia PLC

Wall Street analysts forecast EXAI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXAI is 8.84 USD with a low forecast of 7.07 USD and a high forecast of 10.5 USD.

EXAI Lowest Forecast
Wall Street Target
7.07 USD
76% Upside
EXAI Average Forecast
Wall Street Target
8.84 USD
120% Upside
EXAI Highest Forecast
Wall Street Target
10.5 USD
161% Upside
Lowest
Price Target
7.07 USD
76% Upside
Average
Price Target
8.84 USD
120% Upside
Highest
Price Target
10.5 USD
161% Upside
Exscientia PLC Competitors:
Price Targets
NGNE
Neurogene Inc
69% Upside
LGND
Ligand Pharmaceuticals Inc
69% Upside
B
BAVA
Bavarian Nordic A/S
88% Upside
REGN
Regeneron Pharmaceuticals Inc
21% Upside
NGNE
Neurogene Inc
69% Upside
LGND
Ligand Pharmaceuticals Inc
69% Upside
B
BAVA
Bavarian Nordic A/S
88% Upside
REGN
Regeneron Pharmaceuticals Inc
21% Upside
C
688276
Changchun BCHT Biotechnology Co
75% Upside
BVXP
Bioventix PLC
36% Upside
9995
RemeGen Co Ltd
61% Upside
KURN
Kuros Biosciences AG
192% Upside

Revenue
Forecast

Revenue Estimate
Exscientia PLC

For the last 3 years the compound annual growth rate for Exscientia PLC's revenue is 17%. The projected CAGR for the next 3 years is 4%.

17%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-23%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Exscientia PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Exscientia PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

See Also

Summary
EXAI intrinsic value, competitors valuation, and company profile.
DCF Valuation
EXAI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EXAI stock valuation using valuation multiples.
Wall Street Estimates
EXAI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EXAI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EXAI's stock price target?
Price Target
8.84 USD

According to Wall Street analysts, the average 1-year price target for EXAI is 8.84 USD with a low forecast of 7.07 USD and a high forecast of 10.5 USD.

What is Exscientia PLC's Revenue forecast?
Projected CAGR
4%

For the last 3 years the compound annual growth rate for Exscientia PLC's revenue is 17%. The projected CAGR for the next 3 years is 4%.

ALPHA SPREAD
Join more than 132,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.